Home › Atrial Fibrillation › NCT06007872

Intracardiac Echocardiography Guided Watchman Device Implant

Feasibility: Intracardiac Echocardiography Guided Watchman Device Implant

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All patients who meet guideline established criteria for commercially available Watchman device implant and not enrolled in an active clinical trial

Exclusion Criteria:

* Patients in whom a procedural TEE cannot be performed and an ICE only implant is needed.
* Patients receiving a concomitant ablation procedure
* Patients with prior incomplete surgical or percutaneous left atrial appendage ligation/exclusion procedures
* Patients in whom the delivery of trans-septal equipment is anticipated to be difficult (e.g. patent foramen ovale (PFO) or atrial septal defect (ASD) closure devices in place).

About the study

This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.

What is being tested

• Intracardiac Echocardiography (ICE) (device)

Sponsor: The Cleveland Clinic · Participants: 100 · Started: Dec 2, 2022

Contact the study team

• Oussama Wazni, MD · Phone: 216-444-2131

Official record on ClinicalTrials.gov — NCT06007872

Locations in the U.S.

Conditions

• Atrial Fibrillation

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.